Trial Information

Summary: A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination with Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer

The purpose of the study is to see if ipilimumab given with paclitaxel/carboplatin will have clinical benefit when compared to paclitaxel/carboplatin alone in previously untreated patients with lung cancer.

Inclusion Criteria

• Men or Women 18 Years or Older
• Documented NSCLC or SCLC
• ECOG of 0 or 1

Exclusion Criteria

• Brain Metastases
• Autoimmune Disease
• Known HIV, Hep B or Hep C Infection
• Peripheral Neuropathy ³ Grade 2

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:31 AM